Table 1.
Assessment of the therapeutic potential of HFSC to treat a mouse model of LSCD
Time Post-transplantation |
Number | Goblet Cells Peripheral Cornea |
Vascularization | Ocular Surface Reconstruction |
---|---|---|---|---|
3d | 3 | 0/3 (0%) | 0/3 (0%) | 3/3 (100%) |
1 wk | 5 | 1/5 (20%) | 0/5 (0%) | 4/5 (80%) |
2 wk | 8 | 1/8 (12.5%) | 1/8 (12.5%) | 7/8 (87.5%) |
3 wk | 7 | 2/7 (29%) | 1/7 (14%) | 5/7 (71%) |
5 wk | 5 | 1/5 (20%) | 1/5 (20%) | 4/5 (80%) |
7 wk | 3 | 1/3 (33%) | 1/3 (33%) | 2/3 (67%) |